A systematic review of worldwide incidence of nonmelanoma skin cancer
2012/01/17 by A. Lomas, Andrew Lomas, J. Leonardi‐Bee +3 · 31 citations
Medicine · #Nonmelanoma Skin Cancer Studies #Cutaneous Melanoma Detection and Management #Skin Protection and Aging
paper · doi:10.1111/j.1365-2133.2012.10830.x
Abstract
BACKGROUND: Nonmelanoma skin cancer (NMSC) is the most common cancer affecting white-skinned individuals and the incidence is increasing worldwide. OBJECTIVES: This systematic review brings together 75 studies conducted over the past half century to look at geographical variations and trends worldwide in NMSC, and specifically incidence data are compared with recent U.K. cancer registry data. METHODS: Following the development of a comprehensive search strategy, an assessment tool was adapted to look at the methodological quality of the eligible studies. RESULTS: Most of the studies focused on white populations in Europe, the U.S.A. and Australia; however, limited data were available for other skin types in regions such as Africa. Worldwide the incidence for NMSC varies widely with the highest rates in Australia [>1000/100, 000 person-years for basal cell carcinoma (BCC)] and the lowest rates in parts of Africa (< 1/100, 000 person-years for BCC). The average incidence rates in England were 76·21/100, 000 person-years and 22·65/100, 000 person-years for BCC and squamous cell carcinoma (SCC), respectively, with highest rates in the South-West of England (121·29/100, 000 person-years for BCC and 33·02/100, 000 person-years for SCC) and lowest rates by far in London (0·24/100, 000 person-years for BCC and 14·98/100, 000 person-years for SCC). The incidence rates in the U.K. appear to be increasing at a greater rate when compared with the rest of Europe. CONCLUSIONS: NMSC is an increasing problem for health care services worldwide. This review highlights a requirement for prevention studies in this area and the issues surrounding incomplete NMSC registration. Registration standards of NMSC should be improved to the level of other invasive disease.
Cited by
- Trends in keratinocyte skin cancer incidence, mortality and burden of disease in 33 countries between 1990 and 2017
- Classification of the Clinical Images for Benign and Malignant Cutaneous Tumors Using a Deep Learning Algorithm
- SkinGenBench: Generative Model and Preprocessing Effects for Synthetic Dermoscopic Augmentation in Melanoma Diagnosis
- Dermatoscopy and reflectance confocal microscopy for basal cell carcinoma diagnosis and diagnosis prediction score: A prospective and multicenter study on 1005 lesions
- Basal cell carcinoma
- Dermtrainer: A Decision Support System for Dermatological Diseases
- Polycyclic aromatic hydrocarbons as skin carcinogens: comparison of benzo[a]pyrene, dibenzo[def,p]chrysene and three environmental mixtures in the FVB/N mouse. [europepmc]
- International prevalence of indoor tanning: a systematic review and meta-analysis. [europepmc]
- Apigenin reactivates Nrf2 anti-oxidative stress signaling in mouse skin epidermal JB6 P + cells through epigenetics modifications. [europepmc]
- Recurrent point mutations in the kinetochore gene KNSTRN in cutaneous squamous cell carcinoma. [europepmc]
- Prevalence and costs of skin cancer treatment in the U.S., 2002-2006 and 2007-2011. [europepmc]
- Tumor evolution. High burden and pervasive positive selection of somatic mutations in normal human skin. [europepmc]
- Ultraviolet Radiation Exposure and Its Impact on Skin Cancer Risk. [europepmc]
- Reflectance confocal microscopy of skin in vivo: From bench to bedside. [europepmc]
- Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study. [europepmc]
- The Association Between Adverse Childhood Experiences and Risk of Cancer in Adulthood: A Systematic Review of the Literature. [europepmc]
- Incidence and Trends of Basal Cell Carcinoma and Cutaneous Squamous Cell Carcinoma: A Population-Based Study in Olmsted County, Minnesota, 2000 to 2010. [europepmc]
- Updates on the Management of Non-Melanoma Skin Cancer (NMSC). [europepmc]
- Environmental effects of ozone depletion, UV radiation and interactions with climate change: UNEP Environmental Effects Assessment Panel, update 2017. [europepmc]
- HOXA9 inhibits HIF-1α-mediated glycolysis through interacting with CRIP2 to repress cutaneous squamous cell carcinoma development. [europepmc]
- Nationwide Incidence of Metastatic Cutaneous Squamous Cell Carcinoma in England. [europepmc]
- Teledermatology for diagnosing skin cancer in adults. [europepmc]
- Epidemiology of basal and cutaneous squamous cell carcinoma in the U.K. 2013-15: a cohort study. [europepmc]
- Papillomavirus Immune Evasion Strategies Target the Infected Cell and the Local Immune System. [europepmc]
- Incidence and mortality for cutaneous squamous cell carcinoma: comparison across three continents. [europepmc]
- Phase 2 study of cemiplimab in patients with metastatic cutaneous squamous cell carcinoma: primary analysis of fixed-dosing, long-term outcome of weight-based dosing. [europepmc]
- Non-Melanoma Skin Cancers: Biological and Clinical Features. [europepmc]
- The influence of climate change on skin cancer incidence - A review of the evidence. [europepmc]
- Global, regional and national incidence, mortality and disability-adjusted life-years of skin cancers and trend analysis from 1990 to 2019: An analysis of the Global Burden of Disease Study 2019. [europepmc]
- Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019. [europepmc]
- Overview of skin cancer types and prevalence rates across continents. [europepmc]
Related